Background Acute rejection may be suspected in heart transplant recipients in the setting of new onset of clinical symptoms or alterations in cardiac function. Immediate diagnosis may be obtained by performing a frozen section on endomyocardial biopsy (EMB) specimens. However, little is known about the indications for, and the diagnostic reliability of, this procedure.
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Methods and Results EMBs with frozen section (n=98) from 65 of 214 consecutive orthotopic heart transplant recipients were reviewed and divided into early (s45 days; n=47) and late (>45 days; n=51) posttransplant periods. Frozen section diagnoses (X= 1.5 EMB samples) were compared with corresponding permanent section diagnoses (x=4.4 EMB samples), and clinical indications were analyzed. Comparison of frozen and permanent section interpretation revealed concordant pathological processes-rejection (n=31) versus no rejection (n=37) versus ischemic injury (n=20) -in 88 of 98 (90%) cases. Discordant pathological processes on frozen versus permanent section in 10 of 98 (10%) cases could be attributed to ischemic injury (n=5), sampling (n=4), and infection (n= 1). In the 92 cases with defined clinical indications, the indication and number of EMBs positive for rejection early and late after transplantation were arrhythmia: 2 of 12 early, 4 of 10 late; congestive heart failure: 1 The most common pathological processes diagnosed on frozen section were acute rejection and ischemic injury to the myocardium (Fig 1) . Histological concordance between the pathological processes diagnosed on frozen section and permanent section occurred in 88 of 98 (90%) EMBs (Fig 2) . The the purpose of grading rejection.5 Because rejection may be focal or multifocal, limited sampling on frozen section may miss or underestimate the extent of rejection. The rationale behind using frozen section diagnosis on one to two myocardial samples was to attempt to identify clinically significant rejection (that which warrants increased immunosuppression) or to identify another pathological process responsible for the patient's clinical symptoms (ie, ischemic injury) rather than to provide precise histological grading of rejection. Submitting all of the myocardial samples for frozen section runs the risk of introducing artifact, which could potentially impede interpretation of the permanent sections.
In 88 of 98 cases (90%), there was concordance between frozen and permanent section diagnosis in assessing the presence or absence of rejection or the presence of another pathological process such as ischemic injury. Considering the extremely limited sampling on most frozen sections, it was surprising that, in as many as 28 of 31 (90%) cases identified as having rejection on frozen section, the extent of rejection was judged to be comparable to that on the permanent section, warranting similar treatment for both. Each of the three cases in which the permanent compared with the frozen section may have elicited a different clinical response were diagnosed as a single focus of rejection on frozen section and multiple foci of rejection on additional samples available for permanent section. These three cases provide a good example of the importance of more extensive sampling and illustrate why rendering a grade of rejection should not be attempted with inadequate sampling on permanent as well as on frozen section.
In some situations, however, EMBs that are negative for rejection or that demonstrate processes other than rejection may be as clinically useful as those demonstrating rejection. Ischemic myocyte injury after heart transplantation has been reported to occur in 20% to 89% of EMBs obtained during the first 4 to 6 posttransplant weeks and must be differentiated from rejection.67 Early ischemic injury is characterized by coagulative myocyte necrosis. The accompanying inflammation consists of polymorphonuclear leukocytes, which are replaced during the healing phase by a histiocytic infiltrate admixed with lymphocytes and plasma cells. Frozen section artifact, however, may confound this diagnosis, as was the case in 5 of 10 cases with discordance between frozen section and permanent section diagnoses. Artifactual separation of the myofibers and the appearance of increased interstitial cellularity in combination with the increased thickness of the frozen section preparation all contribute to the difficulty in interpreting frozen sections. Each of the five cases in which ischemic injury resulted in discordant diagnoses between frozen and permanent sections occurred within the first month after transplantation, when ischemic injury is most prevalent. Increased awareness of the high frequency of ischemic injury, especially during the early posttransplant period, may be helpful in interpreting these EMBs and avoiding unnecessary augmentation of immunosuppression.
One of the discordant cases, diagnosed as rejection on frozen section, was found to have CMV infection of the myocardium on permanent sections. 12 The lack of a correlation in our study, especially in the early period after cardiac transplantation, also suggests a low yield for EMB. The mobilization of resources for immediate diagnosis for this indication does not appear to be warranted.
The finding of bradycardia, with or without other clinical findings, was associated with rejection in a higher proportion of patients (5 of 9 for any presentation with bradyarrhythmia). These numbers are small and represent only a small fraction of patients who developed a bradyarrhythmia at some point in the posttransplant period. Prior studies report an incidence of bradyarrhythmia ranging from 4.4% to 18%, without a clear association with rejection.13-16 Nevertheless, a diagnosis of rejection should be considered in patients presenting with bradyarrhythmias, especially late in the posttransplant course.
Overall, rejection was diagnosed in 9 of 43 (21%) patients in the early posttransplant period when clinical suspicion may be heightened and in 18 of 49 (37%) patients in the late posttransplant period. The greatest yield for rapid EMB diagnosis occurred in patients with congestive heart failure symptoms or shortness of breath, noncompliance in taking immunosuppressive medication, and bradyarrythmia. It 
